Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

April 25, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Genzyme Beats Consensus, Increases Full-Year Guidance

April 22, 2005

By Jennifer Boggs

Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

Molecular Insight Raises $28M In Series C For Imaging Product

April 21, 2005

By Jennifer Boggs

Corgentech Cuts Staff To Slow Spending After E2F Decoy Miss

April 21, 2005

By Jennifer Boggs

Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo

April 20, 2005

By Jennifer Boggs

Agennix Reports Positive NSCLC Data With Talactoferrin, Chemo

April 20, 2005

By Jennifer Boggs

Nuvelo Begins Phase III Trial Of Alfimeprase In 'Leg Attack'

April 19, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...